Dina Chaya is a Partner on the Private Equity team at OrbiMed, where they have focused on the healthcare sector since 2023. With experience dating back to 2001, they previously held key roles at Omega Funds, NeoMed Management, 3i Group, and Index Ventures. Their successful investments include Imago BioSciences, CinCor Pharma, and Wilson Therapeutics among others. Dina, a CFA charterholder, holds a Ph.D. in Molecular and Cellular Biology from Pierre and Marie Curie University and has conducted postdoctoral research at Brown University and Fox Chase Cancer Center. They also serve on the board of directors for Monks Investment Trust plc.
This person is not in the org chart
This person is not in any teams
This person is not in any offices